Medipharm Labs Corp Share Price Toronto S.E.
Equities
CA58504D1006
Pharmaceuticals
Sales 2024 * | 43.06M 31.46M 2.62B | Sales 2025 * | 58.43M 42.69M 3.56B | Capitalization | 32.32M 23.62M 1.97B |
---|---|---|---|---|---|
Net income 2024 * | -7M -5.11M -426M | Net income 2025 * | -1M -731K -60.9M | EV / Sales 2024 * | 0.75 x |
Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | 0.55 x |
P/E ratio 2024 * |
-5.33
x | P/E ratio 2025 * |
-
| Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.52% |
Latest transcript on Medipharm Labs Corp
Managers | Title | Age | Since |
---|---|---|---|
David Pidduck
CEO | Chief Executive Officer | - | 20/22/20 |
Greg Hunter
DFI | Director of Finance/CFO | - | 08/21/08 |
Keith Strachan
PSD | President | - | 01/18/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Bumby
BRD | Director/Board Member | 60 | 01/23/01 |
David Pidduck
CEO | Chief Executive Officer | - | 20/22/20 |
Shelley Martin
BRD | Director/Board Member | - | 22/20/22 |
1st Jan change | Capi. | |
---|---|---|
+37.08% | 6.01B | |
-17.43% | 4.4B | |
-9.46% | 3.17B | |
+0.51% | 3.07B | |
-3.53% | 2.51B | |
+41.15% | 1.88B | |
-5.15% | 1.73B | |
+0.09% | 1.65B | |
-10.38% | 1.58B |